Gyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
GYRE Key Statistics
Stock Snapshot
With a market cap of 587.78M, Gyre Therapeutics(GYRE) trades at $6.05. The stock has a price-to-earnings ratio of -80.85.
During the trading session on 2026-06-08, Gyre Therapeutics(GYRE) shares reached a daily high of $6.34 and a low of $5.95. At a current price of $6.05, the stock is +1.7% higher than the low and still -4.6% under the high.
Trading volume for Gyre Therapeutics(GYRE) stock has reached 76.47K, versus its average volume of 108.76K.
The stock's 52-week range extends from a low of $5.44 to a high of $9.42.
The stock's 52-week range extends from a low of $5.44 to a high of $9.42.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.